The effect of functioning, clinical symptoms and related biomarkers in Chinese patients with bipolar disorder

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR1900025993

Enrollment

Unknown

Registered

2019-09-17

Start date

2019-10-01

Completion date

Unknown

Last updated

2019-09-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

bipolar disorder

Interventions

FR :functional remediation

TAU:treatment as usual

Eligibility

Sex/Gender

All

Age

18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. patients with a DSM-5 clinical criteria for bipolar disorder; 2. patients were between 18-60 years old, males and females; 3. patients who demonstrated a HAMD-17 (17-item Hamilton Depression Rating Scale) Score = 12; 5. education levels were above of elementary school; 6. patients provided their written and informed consent.

Exclusion criteria

Exclusion criteria: 1. patients were excluded if they had a history of serious physical, cerebral organic history or alcohol abuse; 2. had serious psychiatric diseases such as schizophrenia or mental retardation; 3. being received other psychological therapy, and MECT or rTMS trratment.

Design outcomes

Primary

Measure	Time frame
total functioning;neurotrophic factors;	—

Secondary

Measure	Time frame
emotional recognition;	—

Countries

China

Contacts

Public ContactZhang Yong

Tianjin Anding Hospital

zhangyong@tjmhc.com+86 22-88188258

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026